Get all premium features to the best stock analysis tool

Genomma Lab Internacional Announces Long-Term Debt Transaction

MEXICO CITY, Aug. 31, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international reach, announces that it has entered into a new MXN $1.0 billion long-term credit facility with Banamex, with a 3-year term.